Andere Sprachen Oxygenta Pharmaceutical Limited

Aktien

SSORGS

INE102E01018

SSORGS

Verzögert Bombay S.E. Andere Börsenplätze 11:42:32 28.06.2024			% 5 Tage	% 1. Jan.
33,53 ^INR	-0,03 %		-6,86 %	+7,61 %

2023	Oxygenta Pharmaceutical Limited berichtet über die Ergebnisse für das zweite Quartal und die sechs Monate bis zum 30. September 2023	CI
2023	Oxygenta Pharmaceutical Limited ernennt Miss. Dolly Mandhan zur Gesellschaftssekretärin des Unternehmens, die als leitende Angestellte und Compliance-Beauftragte benannt wurde	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Oxygenta Pharmaceutical Limited announced that it has received INR 32 million in funding	21.05.
Oxygenta Pharmaceutical Limited announced that it expects to receive INR 32 million in funding	08.04.
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14.11.
Oxygenta Pharmaceutical Limited Appoints Miss. Dolly Mandhan as the Company Secretary of the Company Designated as the Key Managerial Personnel and Compliance Officer	11.10.23
Oxygenta Pharmaceutical Limited Announces Board Appointments	01.10.23
Oxygenta Pharmaceutical Limited Approves Board Changes	04.09.23
Oxygenta Pharmaceutical Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14.08.23
Oxygenta Pharmaceutical Limited Announces Resignation of Veerendra Babu Rangisetti as Company Secretary and Compliance Officer	01.07.23
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30.05.23
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	30.05.23
Sunil Vishram Chawda, Manoj Sunil Chawda, Aakanksha M. Chawda and Raghavender Rao Kanuganti made an offer to acquire a 26% stake in Oxygenta Pharmaceutical Limited for approximately INR 130 million.	27.02.23
Oxygenta Pharmaceutical Limited announced a financing transaction	27.02.23
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14.02.23
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	12.11.22
Oxygenta Pharmaceutical Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	12.08.22
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	14.02.22
SS Organics Adopts New Name	11.02.22
S.S. Organics Ltd. has Changed its Name to Oxygenta Pharmaceutical Limited	10.02.22
S.S. Organics Limited Announces Resignation of Directors	07.12.21
S.S. Organics Limited Announces Resignations of Directors	07.12.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Oxygenta Pharmaceutical Limited

Aktien

SSORGS

INE102E01018

SSORGS

Andere Sprachen

Filter